Clever Culture Systems Ltd
Company Profile
Business description
Clever Culture Systems Ltd provides intelligent automation solutions to microbiology laboratories. The Company has developed a technology, the Automated Plate Assessment System (APAS Independence), using artificial intelligence and machine learning software to automate the imaging, analysis, and interpretation of microbiology culture plates. The technology remains the only U.S. FDA-cleared artificial intelligence technology for automated culture plate reading. The Group operates in one business segment, researching, developing, and commercialising innovative technologies. Its geographic areas are Australia, the UK, Sweden, the Netherlands, and Others. It generates the majority revenue from the Australia region.
Contact
16 Anster Street
AdelaideSA5000
AUST: +61 882271555
Sector
Technology
Stock type
Sensitive
Industry
Software - Infrastructure
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
ASX healthcare giant remains well positioned despite share slump
stocks
Australian bank remains overvalued despite strong result
stocks
Chart of the Week: Soft earnings growth outlook for Australian banks
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,283.40 | 39.70 | -0.43% |
| CAC 40 | 8,313.24 | 14.64 | -0.18% |
| DAX 40 | 24,856.15 | 131.70 | -0.53% |
| Dow JONES (US) | 50,121.40 | 66.74 | -0.13% |
| FTSE 100 | 10,472.11 | 118.27 | 1.14% |
| HKSE | 27,023.67 | 242.71 | -0.89% |
| NASDAQ | 23,066.47 | 36.01 | -0.16% |
| Nikkei 225 | 57,706.29 | 55.75 | 0.10% |
| NZX 50 Index | 13,531.48 | 24.20 | 0.18% |
| S&P 500 | 6,941.47 | 0.34 | -0.00% |
| S&P/ASX 200 | 9,043.50 | 18.50 | -0.20% |
| SSE Composite Index | 4,137.06 | 5.07 | 0.12% |